More Use of Alternative Treatment Without Complications and Expense of Surgery or Radioiodine is Needed for Recurrent Thyroid Cancer in the Lymph Nodes
Before Ethanol Ablation PEI After 10 months post PEI
Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative.
Comments on this article
1.Well-differentiated thyroid cancer (WDTC) recurs in up to 30% of patients.
2. They fail to guide the clinician as to the multitude of factors that should be taken into account.
3. The Thyroid Cancer Care Collaborative (TCCC) is a web-based repository of a patient’s clinical information.
4. Ten clinical decision-making modules (CDMMs) process this information and display individualized treatment recommendations.
5. Surgery remains the most common treatment in recurrent/persistent WDTC.
6. However, careful observation may be the recommended course in select patients.
7. Reoperation yields biochemical remission rates between 21% and 66%.
8. There is a reported 1.2% incidence of permanent unexpected nerve paralysis and a 3.5% incidence of permanent hypoparathyroidism.
9. Percutaneous ethanol ablation has been reported as therapeutic alternatives.
10.Radioactive iodine is not primary therapy for metastatic lymph nodes.
Ethanol ablation PEI saves money and is effective in ablating recurrent thyroid cancer lymph nodes.
Go to Mayo clinic and see Dr. Ian Hay. His study saved 35 patents $1.5 million in surgery costs and did not have one single major complication of nerve or parathyroid damage.
or see me for the same PEI therapy.
Call Matt at 310-393-8860 or email@example.com for details if you have been told
to risk more complication potential with another neck surgery.
Richard Guttler MD,FACE,ECNU